Curcumin derivatives inhibit testicular 17β-hydroxysteroid dehydrogenase 3

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 8, 2010, Pages 2549-2551

  Hu, Guo Xin ^a   Liang, Guang ^a   Chu, Yanhui ^c   Li, Xiaokun ^a   Lian, Qing Quang ^a   Lin, Han ^a   He, Yi ^a   Huang, Yadong ^b,d   Hardy, Dianne O ^b   Ge, Ren Shan ^a,b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b POPULATION COUNCIL   (United States)

^c MUDANJIANG MEDICAL UNIVERSITY   (China)

^d JINAN UNIVERSITY   (China)

Author keywords

17 HSD3; Androgens; Curcumin derivatives; Leydig cells; Steroidogenesis; Steroids

Indexed keywords

CURCUMIN; CURCUMIN DERIVATIVE; TESTOSTERONE 17BETA DEHYDROGENASE; TESTOSTERONE 17BETA DEHYDROGENASE 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; LEYDIG CELL; MALE; MICROSOME; NONHUMAN; RAT; REACTION ANALYSIS;

17-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; CURCUMIN; ENZYME INHIBITORS; HUMANS; MALE; RATS; TESTIS;

RATTUS;

EID: 77950058417     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.02.089     Document Type: Article

References (18)

1. Ge R.S., and Hardy M.P. Endocrinology 139 (1998) 3787
2. Geissler W.M., Davis D.L., Wu L., Bradshaw K.D., Patel S., Mendonca B.B., Elliston K.O., Wilson J.D., Russell D.W., and Andersson S. Nat. Genet. 7 (1994) 34
3. Andersson S., and Moghrabi N. Steroids 62 (1997) 143
4. Day J.M., Tutill H.J., Purohit A., and Reed M.J. Endocrinol. Relat. Cancer 15 (2008) 665
5. Ngatcha B.T., Luu-The V., and Poirier D. Bioorg. Med. Chem. Lett. 10 (2000) 2533
6. Maltais R., Luu-The V., and Poirier D. Bioorg. Med. Chem. 9 (2001) 3101
7. Maltais R., Luu-The V., and Poirier D. J. Med. Chem. 45 (2002) 640
8. Le Lain R., Nicholls P.J., Smith H.J., and Maharlouie F.H. J. Enzyme Inhib. 16 (2001) 35
9. Sakamoto K., and Wakabayashi K. Endocrinol. Jpn. 35 (1988) 333
10. Spires T.E., Fink B.E., Kick E.K., You D., Rizzo C.A., Takenaka I., Lawrence R.M., Ruan Z., Salvati M.E., Vite G.D., Weinmann R., Attar R.M., Gottardis M.M., and Lorenzi M.V. Prostate 65 (2005) 159
11. Lo Y.H., Sheff M.F., Latif S.A., Ribeiro C., Silver H., Brem A.S., and Morris D.J. Hypertension 29 (1997) 500
12. Liang G., Yang S., Jiang L., Zhao Y., Shao L., Xiao J., Ye F., Li Y., and Li X. Chem. Pharm. Bull. (Tokyo) 56 (2008) 162
13. 3H-androstenedione (Dupont-New England Nuclear, Boston, MA) and 0.2 mM NADPH (for microsomes only) for 1.5-2 h. Steroids were separated by thin layer chromatography and scanned by a scanning radiometer (System AR2000, Bioscan Inc., Washington, DC). Various concentrations of curcumin (Sigma-Aldrich, St. Louis, MO) and its derivatives (synthesized as previously described) were used.
14. 6 Leydig cells were cultured for 24 h in DMEM:F12 with various concentrations of curcumin in the absence or presence of 1 ng/ml LH. T present in medium was measured by a tritium-based radioimmunoassay (RIA).
15. Kang G., Kong P.J., Yuh Y.J., Lim S.Y., Yim S.V., Chun W., and Kim S.S. J. Pharmacol. Sci. 94 (2004) 325
16. Tsvetkov P., Asher G., Reiss V., Shaul Y., Sachs L., and Lotem J. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 5535
17. Ammon H.P., and Wahl M.A. Planta Med. 57 (1991) 1
18. Cheng A.L., Hsu C.H., Lin J.K., Hsu M.M., Ho Y.F., Shen T.S., Ko J.Y., Lin J.T., Lin B.R., Ming-Shiang W., Yu H.S., Jee S.H., Chen G.S., Chen T.M., Chen C.A., Lai M.K., Pu Y.S., Pan M.H., Wang Y.J., Tsai C.C., and Hsieh C.Y. Anticancer Res. 21 (2001) 2895